Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Antineoplaston Therapy in Treating Patients With Brain Tumors				Phase II				BC-BT-9 NCT00003457
	Temozolomide in Treating Patients With Invasive Pituitary Tumors				Phase II				UCLA-06-12-080 06-12-080, SPRI-UCLA-06-12-080, 07-05-077-01, NCT00601289
	Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing's Disease)				Phase II				UCLA-0612080-01 06-12-080-01, NCT00612066
	Rosiglitazone in Treating Patients With Pituitary Tumors				Phase II				UCLA-0411082-03 04-11-082-03, NCT00616642

| | | | | | | |

A Service of the National Cancer Institute